Search
Last update: : 28.11.2025
Lilli-Joelle Kohler +49 6221 42 2856 M300 B250 Trainee
Last update: : 28.11.2025
As a clinician scientist at the German Cancer Research Center (DKFZ) and the Mannheim Medical Faculty of Heidelberg University, neurologist Lukas Bunse is investigating how the body's own immune…
Press releaseLast update: : 28.11.2025
EpiPROPER: Identifying epigenetic determinants of drug resistance via characterization of drug-tolerant persister cells in triple negative breast cancer Intrinsic and acquired resistance to therapy…
Last update: : 28.11.2025
Menu December 01st to December 05th 25 (week 49) Monday Tuesday Main component Chicken fricassee with carrots and mushrooms(3,26,28) Wednesday **Hearty pea stew, vegan, with carrots, celery and…
DocumentLast update: : 28.11.2025
Head of Division Secretary Scientists PhD Students Technicians Master Students Interns Our Division is a dynamic, international…
Last update: : 28.11.2025
Major Research Direction In the Epigenomics of hormone-driven cancers group, current projects focus on The role of 5-hydroxymethylation in cancer Profiling DNA hydroxy-/methylation and…
Last update: : 28.11.2025
PATHWAY-27 The general objective of PATHWAY-27 project addresses the exploitation of bioactive compounds as ingredients of foods that, within the common diet, could significantly benefit human…
Last update: : 28.11.2025
Endocrine therapy to block the estrogen receptor pathway in breast cancer is highly effective, but its usefulness is limited by common intrinsic and acquired resistance. In up to 20% of patients…
Last update: : 28.11.2025
Prostate cancer is the most frequent malignant tumor in males and the second most frequent cause of cancer-related death. Currently, in Germany, more than 60,000 prostate cancers are diagnosed…